Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Locomotion and self-administration induced by cocaine in 129/OlaHsd mice lacking galanin.

Brabant C, Kuschpel AS, Picciotto MR.

Behav Neurosci. 2010 Dec;124(6):828-38. doi: 10.1037/a0021221.

2.

Neurocircuitry of addiction.

Koob GF, Volkow ND.

Neuropsychopharmacology. 2010 Jan;35(1):217-38. doi: 10.1038/npp.2009.110. Review. Erratum in: Neuropsychopharmacology. 2010 Mar;35(4):1051.

3.

Effects of galanin on monoaminergic systems and HPA axis: Potential mechanisms underlying the effects of galanin on addiction- and stress-related behaviors.

Picciotto MR, Brabant C, Einstein EB, Kamens HM, Neugebauer NM.

Brain Res. 2010 Feb 16;1314:206-18. doi: 10.1016/j.brainres.2009.08.033. Epub 2009 Aug 20. Review.

4.

Effects of galanin on cocaine-mediated conditioned place preference and ERK signaling in mice.

Narasimhaiah R, Kamens HM, Picciotto MR.

Psychopharmacology (Berl). 2009 May;204(1):95-102. doi: 10.1007/s00213-008-1438-7. Epub 2008 Dec 20.

5.

Review. Neurobiological mechanisms for opponent motivational processes in addiction.

Koob GF, Le Moal M.

Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3113-23. doi: 10.1098/rstb.2008.0094. Review.

6.

Galanin and addiction.

Picciotto MR.

Cell Mol Life Sci. 2008 Jun;65(12):1872-9. doi: 10.1007/s00018-008-8151-x. Review.

PMID:
18500649
7.

Galanin protects against behavioral and neurochemical correlates of opiate reward.

Hawes JJ, Brunzell DH, Narasimhaiah R, Langel U, Wynick D, Picciotto MR.

Neuropsychopharmacology. 2008 Jul;33(8):1864-73. Epub 2007 Oct 24.

8.
9.
11.
12.

Behavioural characterisation of transgenic mice overexpressing galanin under the PDGF-B promoter.

Kuteeva E, Hökfelt T, Ogren SO.

Neuropeptides. 2005 Jun;39(3):299-304.

PMID:
15944026
13.
14.

Galanin acts as a neuroprotective factor to the hippocampus.

Elliott-Hunt CR, Marsh B, Bacon A, Pope R, Vanderplank P, Wynick D.

Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):5105-10. Epub 2004 Mar 23.

15.

Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention.

Zambrowicz BP, Abuin A, Ramirez-Solis R, Richter LJ, Piggott J, BeltrandelRio H, Buxton EC, Edwards J, Finch RA, Friddle CJ, Gupta A, Hansen G, Hu Y, Huang W, Jaing C, Key BW Jr, Kipp P, Kohlhauff B, Ma ZQ, Markesich D, Payne R, Potter DG, Qian N, Shaw J, Schrick J, Shi ZZ, Sparks MJ, Van Sligtenhorst I, Vogel P, Walke W, Xu N, Zhu Q, Person C, Sands AT.

Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14109-14. Epub 2003 Nov 10.

16.

The neuropeptide galanin modulates behavioral and neurochemical signs of opiate withdrawal.

Zachariou V, Brunzell DH, Hawes J, Stedman DR, Bartfai T, Steiner RA, Wynick D, Langel U, Picciotto MR.

Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):9028-33. Epub 2003 Jul 9.

17.

Critical role for GALR1 galanin receptor in galanin regulation of neuroendocrine function and seizure activity.

Jacoby AS, Hort YJ, Constantinescu G, Shine J, Iismaa TP.

Brain Res Mol Brain Res. 2002 Nov 15;107(2):195-200.

PMID:
12487125
18.

Restricted distribution of galanin receptor 3 (GalR3) mRNA in the adult rat central nervous system.

Mennicken F, Hoffert C, Pelletier M, Ahmad S, O'Donnell D.

J Chem Neuroanat. 2002 Nov;24(4):257-68.

PMID:
12406501
19.

Microdialysis in freely moving mice: determination of acetylcholine, serotonin and noradrenaline release in galanin transgenic mice.

Kehr J, Yoshitake T, Wang FH, Wynick D, Holmberg K, Lendahl U, Bartfai T, Yamaguchi M, Hökfelt T, Ogren SO.

J Neurosci Methods. 2001 Aug 15;109(1):71-80.

PMID:
11489302
20.

Galanin receptor 1 gene expression is regulated by cyclic AMP through a CREB-dependent mechanism.

Zachariou V, Georgescu D, Kansal L, Merriam P, Picciotto MR.

J Neurochem. 2001 Jan;76(1):191-200.

Supplemental Content

Support Center